Laboratory Medicine ›› 2020, Vol. 35 ›› Issue (12): 1288-1290.DOI: 10.3969/j.issn.1673-8640.2020.012.020
Previous Articles Next Articles
Received:2019-11-29
Online:2020-12-30
Published:2020-12-31
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2020.012.020
| 组别 | DD | hs-CRP |
|---|---|---|
| 观察组 | 19.84±3.88* | 22.54±2.89* |
| 对照组 | 0.35±0.11 | 3.58±0.21 |
| 组别 | DD | hs-CRP |
|---|---|---|
| 观察组 | 19.84±3.88* | 22.54±2.89* |
| 对照组 | 0.35±0.11 | 3.58±0.21 |
| DD | hs-CRP | 合计 | |
|---|---|---|---|
| 阳性 | 阴性 | ||
| 阳性 | 249 | 9 | 258 |
| 阴性 | 6 | 4 | 10 |
| 合计 | 255 | 13 | 268 |
| DD | hs-CRP | 合计 | |
|---|---|---|---|
| 阳性 | 阴性 | ||
| 阳性 | 249 | 9 | 258 |
| 阴性 | 6 | 4 | 10 |
| 合计 | 255 | 13 | 268 |
| 项目 | 敏感性 | 特异性 | 准确性 |
|---|---|---|---|
| hs-CRP | 95.15（255/268） | 81.60（111/136） | 90.60（366/404） |
| DD | 96.20（258/268） | 89.70（122/136） | 94.05（380/404） |
| hs-CRP+DD | 98.50（264/268） | 93.30（127/136） | 96.78（391/404） |
| 项目 | 敏感性 | 特异性 | 准确性 |
|---|---|---|---|
| hs-CRP | 95.15（255/268） | 81.60（111/136） | 90.60（366/404） |
| DD | 96.20（258/268） | 89.70（122/136） | 94.05（380/404） |
| hs-CRP+DD | 98.50（264/268） | 93.30（127/136） | 96.78（391/404） |
| [1] | 范百亚. 尼莫地平治疗急性脑出血血清超敏C-反应蛋白、白细胞介素-6、高迁移率蛋白-1的变化及效果观察[J]. 解放军医药杂志,2017,29(2):91-94. |
| [2] | DOWLATSHAHI D,WASSERMAN J K,MOMOLI F,et al.Evolution of computed tomography angiography spot sign is consistent with a site of active hemorrhage in acute intracerebral hemorrhage[J]. Stroke,2014,45(1):277-280. |
| [3] | QUINONES-HINOJOSA A,GULATI M,SINGH V,et al. Spontaneous intracerebral hemorhage due to coagulation disorder[J]. Neurosurg Focus,2003,15(4):E3. |
| [4] | CHENG X,ZHANG L,XIE N C,et al.High plasma levels of D-dimer are independently associated with a heightened risk of deep vein thrombosis in patients with intracerebral hemorrhage[J]. Mol Neurobiol,2016,53(8):5671-5678. |
| [5] | 王新德. 各类脑血管疾病诊断要点[J]. 中国乡村医药,1996,2:10-11. |
| [6] | 李凤增,王永红,陈辉. 血常规参数在脑出血急性期预后判断中的价值[J]. 中国老年学杂志,2011,31(12):2168-2170. |
| [7] | 黄华,陈林兴,蔡壁新,等. 心肌肌钙蛋白I、超敏C反应蛋白和尿酸联合检测在急性心肌梗死诊断中的意义[J]. 中国临床实用医学,2009,3(11):19-22. |
| [8] | 魏华,黄金秀,蔡海荣,等. 佛山地区急性脑出血中医证型与HS-CRP和IL-1的相关性研究[J]. 山西中医,2018,34(1):46-48. |
| [9] | 张玲,邢冬梅,夏国斌,等. 超敏C反应蛋白与急性脑出血的预后初探[J]. 昆明医学院学报,2010,31(4):122-125. |
| [10] | 高玉芳,赵联营,王敏,等. 血浆D-二聚体检测在急性脑出血中的临床价值[J]. 国际检验医学杂志,2015,36(6):721-722. |
| [11] | 张景伟. 血浆大内皮素1与D-二聚体联合检测对急性缺血性脑卒中再出血的预测价值[J]. 中国全科医学,2014,17(33):3926-3928. |
| [12] | LIVELY S,SCHLICHTER LC.SC1/hevin identifies early white matter injury after ischemia and intracerebral hemorrhage in young and aged rats[J]. J Neuropathol Exp Neurol,2012,17(6):480-493. |
| [13] | 罗燕飞,林燕珍,李广华,等. 探索血浆D-二聚体在高血压性脑出血急性期中的变化[J]. 中山大学学报(医学科学版),2009,30(S1):163-166. |
| [14] | 马秀清,贾海菊,秦惠萍,等. 青海地区急性脑梗死患者IL-6等8项指标的变化[J]. 检验医学,2019,34(9):821-825. |
| [15] | 沈建成. 急性脑梗死患者血清D-二聚体水平和高敏C-反应蛋白水平检测的临床意义[J]. 检验医学,2011,26(3):202-203. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
